Abbreviations {#nom0001}
=============

AAL

:   automated anatomical labelling

cAEC

:   corrected amplitude envelope correlation

DBS

:   deep brain stimulation

FDR

:   false discovery rate

HPI

:   head position indicator

LEDD

:   levodopa equivalent daily dose

LFP

:   local field potential

MDS-UPDRS-III

:   Movement Disorders Society Unified Parkinson\'s Disease Rating Scale, motor part

MEG

:   magnetoencephalography

PLI

:   phase lag index

ROI

:   region of interest

SL

:   synchronization likelihood

SNR

:   signal-to-noise ratio

STN

:   subthalamic nucleus

tSSS

:   temporal extension of signal space separation

1. Introduction {#sec0001}
===============

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established and effective symptomatic treatment for the disabling medication-related response fluctuations in the motor symptoms of Parkinson\'s disease ([@bib0006]; [@bib0022]). Tremor relief most likely involves different neuronal mechanisms than the reductions in bradykinesia and rigidity ([@bib0030]; [@bib0049]). Local field potential (LFP) studies have demonstrated that excessive beta band synchronized oscillatory activity in the basal ganglia is a hallmark of Parkinson\'s disease and that DBS-induced suppression of these oscillations in the STN goes hand in hand with improvement of both bradykinesia and rigidity ([@bib0014]; [@bib0027]; [@bib0045]). Beta band oscillations have therefore been labelled as "anti-kinetic" ((Peter [@bib0013]), see also ([@bib0052]) for a recent discussion on this topic).

Recent observations suggest that DBS-related neurophysiological effects extend beyond the major components of the classical motor system ([@bib0002]; [@bib0004]; [@bib0015]; [@bib0017]; [@bib0043]; [@bib0050]; [@bib0059]) (for reviews on this topic see ([@bib0008]; [@bib0028])). A better understanding of these effects is not only necessary to explain the neurophysiological mechanisms of DBS but might also aid in the development of an in-vivo biomarker for short and long-term therapeutic effects.

At the cortical level, STN-DBS can modulate oscillatory brain activity in several frequency bands. In two recent studies, STN-DBS lowered theta, alpha and low-beta band power in ([@bib0002]); source-space analysis) and over (([@bib0050]); sensor-space analysis) the sensorimotor cortex, but without a correlation with motor improvement ([@bib0002]; [@bib0050]). Other studies demonstrated that an alpha and beta power suppression over right temporal brain regions correlated positively with DBS-related global motor improvement ([@bib0017]), whereas the average frequency of cortical oscillations seemed to increase upon stimulation ([@bib0004]; [@bib0015]).

Neural circuits involved in Parkinson\'s disease symptoms can be subdivided into different parallel circuits that generally concern cortico-subcortical interactions ([@bib0052]; [@bib0056]). STN-DBS might have opposing functional effects on these circuits as well as their elements. In an fMRI study, dynamic causal modelling revealed a reduction in effective connectivity of the hyperdirect pathway, whereas effective connectivity of the direct, cortico-striatal and thalamo-cortical pathways was increased upon stimulation ([@bib0043]). Oswal and co-workers confirmed that stimulation of the STN suppressed upper-beta band coherence between the STN and cortical motor areas, possibly reflecting the hyperdirect pathway. However, these changes did not correlate with clinical improvement, whereas suppression of low-beta band power in the STN did ([@bib0059]).

Using magnetoencephalography (MEG), Parkinson\'s disease related oscillatory activity can be studied with an excellent spatial and temporal resolution ([@bib0005]; [@bib0059]). MEG data can even be recorded successfully during DBS, in spite of the contamination of recordings by hardware and stimulation artefacts (see ([@bib0001]; [@bib0060]) for a detailed description of DBS-related artefacts). To date, no studies have reported on the influence of DBS on whole-brain functional connectivity including cortico-subcortical connections. Here we investigated this influence using MEG in order to study the alleged anti-kinetic nature of beta band oscillations and to elucidate the neurophysiological correlates of DBS motor-effects.

We used the Amplitude Envelope Correlation (AEC; the correlation between the temporal evolution of spectral power in different regions) as a measure of functional connectivity ([@bib0012]). The AEC is dissociated from local oscillatory processes, and therefore complementary to band power analysis ([@bib0038]). In addition, the AEC has shown similarities with fMRI connectivity ([@bib0011]), thereby allowing a direct comparison with fMRI data. Spurious correlations can be accounted for by using an orthogonalisation method ([@bib0019]; [@bib0038]).

In line with previous whole-brain studies ([@bib0004]; [@bib0015]; [@bib0017]; [@bib0031]; [@bib0043]), we expected the DBS-effects to extend beyond the 'classical' motor system. In addition, since DBS has been shown to influence oscillations in the alpha and low-beta band ([@bib0002]; [@bib0050]) and functional connectivity in the low and high-beta band ([@bib0059]), we hypothesized that alpha and beta band functional connectivity changes would reflect symptom relief upon DBS in Parkinson\'s disease. We therefore performed resting-state MEG recordings with and without STN-DBS stimulation, at least six months after DBS electrode placement. In addition, we assessed whether functional connectivity changes correlated with improvement in motor function, measured using the motor part of the Unified Parkinson\'s Disease Rating Scale (MDS-UPDRS-III).

2. Materials and methods {#sec0002}
========================

2.1. Patients {#sec0003}
-------------

Parkinson\'s disease patients who had undergone bilateral implantation of STN DBS electrodes between 2016 and 2018 at Amsterdam UMC, location AMC, were included in this study. Eligibility for STN DBS placement has been described previously ([@bib0020]). In the context of standard clinical care, the active contacts, voltage, pulse width and frequency of stimulation were individually determined for optimal therapeutic efficacy. Inclusion criteria for the study were: bilateral Boston Scientific Vercise Directed (Valencia, CA, USA) stimulation system (as pilot results demonstrated that this stimulation system was most compatible with our MEG system with respect to the head position estimation; when using a Medtronic Activa PC system (Minneapolis, Minnesota, USA) the noise introduced by the stimulator was such that the head position indicator coils could not be localised by the MEG system), DBS placement at least six months before the MEG recordings, and monopolar stimulation. Exclusion criteria were treatment with levodopa continuous intestinal gel or subcutaneous apomorphine, and permanent post-operative structural damage following DBS electrode placement that could affect the MEG results (apart from the DBS-placement itself).

Disease duration was calculated on the basis of the patients' estimation of the onset of the classical Parkinson\'s disease motor symptoms. The total dose of dopamine replacement therapy was converted to the levodopa equivalent daily dose (LEDD), as described previously (Olde [@bib0058]). The research protocol was approved by the medical ethical committee of the Amsterdam UMC, location VUmc. Ethics review criteria conformed to the Helsinki declaration. After careful explanation of the procedures, all patients gave written informed consent.

2.2. Data acquisition {#sec0004}
---------------------

MEG data were recorded using a 306-channel whole-head system (Elekta Neuromag Oy, Helsinki, Finland) in an eyes-closed resting-state condition, with a sample rate of 1250 Hz, and online anti-aliasing (410 Hz) and high-pass (0.1 Hz) filters. Anatomical T1-weighted images of the head were obtained using a 3T MRI scanner (Philips Ingenia, Best, the Netherlands) in the context of standard clinical care before DBS placement. The study visit took place after an overnight withdrawal of dopaminergic medication (practically defined OFF state). The head position relative to the MEG sensors was recorded continuously using the signals from five head position indicator (HPI) coils. The HPI positions were digitized before each recording, as well as the outline of the patient\'s scalp (\~500 points), using a 3D digitizer (Fastrak, Polhemus, Colchester, VT, USA). For each patient total MEG recording time was 55 min, consisting of 11 trials of 5 min each in which different stimulation settings were explored. At the beginning of each individual trial, localization of the HPI coils was performed in the DBS OFF condition, following which one of the researchers, who monitored the patient inside the magnetically shielded room, changed the DBS-settings and recordings were started. During the recordings, the programming device was kept (offline) in the magnetically shielded room on a stable underground, at approximately 2.5 m distance from the MEG helmet. The experimental setup can be appreciated from [Fig. 1](#fig0001){ref-type="fig"}.Fig. 1Experimental setup.Overview of the different DBS settings during the MEG recordings. The bilateral electrodes, each having four contact points are depicted (the two middle contact points consisted of triplets of segments, together used as one contact point). During the first MEG recording (1) both electrodes were stimulated in the optimal settings of the patient. The second to tenth MEG recordings took place in a randomized order, during which each of the eight individual contact points were stimulated once (2 & 6, dorsal; 3 & 7, dorsomedial; 4 & 8, ventromedial; 5 & 9 ventral; outside the scope of this study), and one recording took place during DBS OFF (10). During the last MEG recording, both electrodes were, again, stimulated in the optimal settings of the patient (11).Fig 1

The first recording was during stimulation with the standard (optimal) DBS settings of the individual patient (DBS ON). Then, nine recordings took place in randomized order, eight of which were during unilateral stimulation of one of the eight individual contact points (data not shown), and one recording during DBS OFF. The last recording was, again, during stimulation with the standard DBS settings of each individual patient (DBS ON2; data analysed as supplementary analysis). The time between recordings, including change of DBS settings and localization of the HPI coils, was at least 2 min.

MDS-UPDRS-III scores were measured during DBS ON and OFF on a separate day by trained nurses, approximately six months after DBS-placement. In accordance with the MEG-recordings, these scores were obtained in the dopamine OFF-state.

2.3. Data pre-processing {#sec0005}
------------------------

MEG channels that were malfunctioning, for example due to excessive noise, were removed after visual inspection of the data. Thereafter, the temporal extension of Signal Space Separation (tSSS; ([@bib0066]; [@bib0067])) in MaxFilter software (Elekta Neuromag Oy, version 2.2.15) was applied with a sliding window of 10 s, origin (0,0,40), and harmonic expansions of 8 respectively 3 for the internal and external signals (all default settings), as well as subspace correlation-limit of 0.8 to suppress the strong magnetic artefacts, which has previously been demonstrated to result in satisfactory data quality without suppression of brain signals ([@bib0010]; [@bib0018]; [@bib0053]; [@bib0066]). An example of the effect of tSSS on MEG data recorded in our study is depicted in Supplementary Fig. 1. Patient\'s MEG data were co-registered to their structural MRIs using a surface-matching procedure, with an estimated resulting accuracy of 4 mm ([@bib0069]). A single sphere was fitted to the outline of the scalp as obtained from the co-registered MRI, which was used as a volume conductor model for the beamformer approach described below.

The automated anatomical labelling (AAL) atlas was used to label the voxels in 78 cortical and 12 subcortical regions of interest (ROIs) ([@bib0025]; [@bib0068]). We used each ROI\'s most central voxel (centroid) as the representative for that ROI ([@bib0037]). Subsequently, an atlas-based beamformer approach was used to project broad-band (0.5--48 Hz) filtered sensor signals to these centroid voxels ([@bib0033]), resulting in broad-band time-series for each centroid of the 90 ROIs. MEG data were visually inspected (by LIB) for tremor-, motion- and stimulation-related artefacts and drowsiness. In addition, for each recording, the 50% epochs with the slowest peak frequency were discarded in order to make the occurrence of drowsiness in the selected data even more unlikely. Epochs contained 4096 samples (3.28 s), and for each condition, 20 epochs with the best quality recordings were selected for further analysis. Spectral and functional connectivity analyses were performed using in-house software (BrainWave, version 0.9.152.12.26; CJS, available from <https://home.kpn.nl/stam7883/brainwave.html>). For frequency band specific analyses, epochs were filtered in six frequency bands (delta (0.5--4 Hz), theta (4--8 Hz), alpha1 (8--10 Hz), alpha2 (10--13 Hz; as the distinction between alpha1 and alpha2 oscillations does have functional significance ([@bib0044])), low-beta (13--22 Hz) and high-beta (22--30 Hz), using a fast Fourier Transform.

2.4. Data analysis {#sec0006}
------------------

We estimated the overall absolute spectral power (0.5--48 Hz) averaged over all ROIs and normalised based on the maximum power peak ([Fig. 2](#fig0002){ref-type="fig"}), as well as the absolute spectral power for each frequency band and ROI separately ([Fig. 3](#fig0003){ref-type="fig"}). Peak frequency values were estimated within the 4--13 Hz frequency range.Fig. 2Overall power spectrum.Average of normalised frequency spectra for all patients (*n* = 18) and all regions of interest (*n* = 90), shaded areas indicate standard error of the means. Despite tSSS filtering and the beamforming approach, stimulation artefact peaks remained present at 27 Hz and 35 Hz during DBS ON (red). DBS, deep brain stimulation; tSSS, spatiotemporal Signal Space Separation. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig 2Fig. 3Regional band power changes.Distribution of significant differences (*p* \< 0.05, FDR corrected) in absolute band power between DBS ON and DBS OFF. Significant increases (decreases) are displayed in red (blue) on a parcellated template brain viewed from, in clockwise order, the left, top, right, left-midline and right-midline. For visualisation purposes, only cortical brain regions are displayed. During DBS ON, a decrease in (mostly occipital) power was observed in the delta and theta band, and an increase in band power was observed in the alpha2, low-beta and high-beta band, suggesting a spectral shift towards the higher frequencies during DBS ON. Note that the sensorimotor regions were hardly involved in this shift and, instead, showed a decrease in absolute band power for the delta, theta, alpha1, alpha2 and low-beta band.Fig 3

For each epoch, frequency-band specific functional connectivity was estimated using the corrected cAEC, an implementation of the AEC ([@bib0012]) corrected for volume conduction/field spread, using a symmetric orthogonalisation procedure ([@bib0012]; [@bib0038]). The cAEC was calculated for all possible pairs of ROIs, leading to a 90×90 adjacency matrix that contained the functional connectivity values between all ROI pairs.

2.5. Statistical analysis {#sec0007}
-------------------------

For each patient, stimulation condition and frequency band separately, absolute power and cAEC matrices were averaged over 20 epochs. Both mean absolute power and mean cAEC per ROI, hence, functional connectivity of one ROI with the rest of the brain, were compared between the ON and OFF stimulation condition using permutation tests ([@bib0051]; [@bib0057]) (*N* = 10,000; *p* \< 0.05). Correction for false positives was performed using the 'false discovery rate' (FDR), separately for each frequency band, with a p-value for each of the 90 ROIs as input ([@bib0007]).

The correlations between DBS-related improvement in motor function and changes in functional connectivity were estimated using Spearman tests (without correction for multiple comparisons due to the exploratory nature of the analysis), where percentage improvement in total MDS-UPDRS-III, bradykinesia/rigidity (items 3--7) and tremor (items 15--18) scores were used as measures of motor improvement. Functional connectivity changes were obtained for all six frequency bands averaged over ROIs in i) the sensorimotor cortices (bilateral pre and post-central gyri), ii) all cortical regions, and iii) all subcortical regions. Only patients who had tremor during DBS OFF were selected for correlation analyses on tremor improvement.

2.6. Data availability statement {#sec0008}
--------------------------------

The data and codes used in this study are available from the corresponding author, upon reasonable request.

3. Results {#sec0009}
==========

3.1. Patients {#sec0010}
-------------

Twenty-one Parkinson\'s disease patients participated in this study and underwent MEG recordings at Amsterdam UMC, location VUmc, at least 6 months after DBS placement (range 6--15 months). Three patients were excluded from further analysis since their MEG data had too many dysfunctional channels during stimulation (\>\~13 channels, caused by excessive noise), which prevented the use of tSSS. This led to a final group of 18 Parkinson\'s disease patients treated with DBS (mean age 58.4 y, SD 8.3), whose characteristics are summarized in [Table 1](#tbl0001){ref-type="table"}. Thirteen patients suffered from tremor and were used for correlations between functional connectivity changes and tremor effects of DBS (paragraph 3.4). The mean number of excluded MEG channels was 9 for DBS ON recordings (range: 5--13) and 6 for DBS OFF recordings (range: 2--12).Table 1Patient characteristics.Table 1PatientAge (years)SexDisease duration (years)Stimulation parameters (stimulation side; contact point on electrode; intensity (mA))Pulse width and stimulation frequencyLevodopa equivalent dose (mg/day)Motor MDS-UPDRS (III)Tremor subscore (MDS-UPDRS (III))Pre-DBSPost-DBSMed OFF/pre-DBSMed OFF/DBS OFFMed OFF/DBS ONMed OFF/DBS OFFMed OFF/DBS ON138M8L; DM; 2.9\
R; VM; 3.460 µs\
179 Hz164499673543194263F5L; DM; 1.7\
R; DM; 1.760 µs\
130 Hz49556743161100365F27L; VM; 2.7\
R; DM; 1.560 µs\
130 Hz50040033201943449F10L; D; 1.9\
R; D; 2.560 µs\
130 Hz79753635372210569M12L; DM; 2.1\
R; DM; 2.160 µs\
130 Hz183015056241420660M8L; DM; 3.2\
R; DM; 1.360 µs\
179 Hz120030057653880753M11L; DM; 2.9\
R; DM; 1.960 µs\
130 Hz1567104360443043866F8L; VM; 2.2\
R; DM; 1.860 µs\
130 Hz1226753473733116945M5L; D; 1.7\
R; DM; 1.760 µs\
130 Hz14102835080441221070F25L; DM; 2.1\
R; DM; 2.460 µs\
130 Hz1590555463315001166M10L; DM; 2.5\
R; DM; 1.860 µs\
149 Hz750575385427731255M8L; DM; 2.7\
R; DM; 2.660 µs\
130 Hz950775423115001357M11L; VM; 1.6\
R; VM; 1.660 µs\
130 Hz113460638217001461M7L; VM; 1.5\
R; VM; 2.160 µs\
130 Hz1000375302711201560M14L; DM; 2.0\
R; VM; 2.560 µs\
130 Hz107342555277311657M12L; VM; 3.1\
R; VM; 2.360 µs\
130 Hz1380720805226531761M8L; DM; 1.8\
R; DM; 2.360 µs\
130 Hz1726946565221811856M12L; DM; 1.4\
R; VM; 1.360 µs\
130 Hz2131124545201000Mean (SD)58 (8)M, *n* = 13; F, *n* = 511 (6)L: 2.2 (0.54)\
R: 2.0 (0.52)1245\
(456)625 (294)49 (13)39 (18)21 (11)4 (4)1 (2)[^1]

3.2. Spectral power {#sec0011}
-------------------

[Fig. 2](#fig0002){ref-type="fig"} shows global stimulation-related normalized spectral power for all Parkinson\'s disease patients. The peak frequency was significantly (and, for all but one patient, consistently) higher during stimulation ON compared to stimulation OFF (DBS ON 8.79 Hz ± 0.69; DBS OFF 8.54 ± 0.64 Hz; t(17) = 5.16; *p* \< 0.001). Two stimulation-related spectral peaks were not removed by tSSS and beamforming. For all patients, these peaks were present around 27 Hz and 35 Hz. [Fig. 3](#fig0003){ref-type="fig"} displays significant differences in absolute power per frequency band between DBS ON and DBS OFF. During DBS ON, a decrease in (mostly occipital) power was observed in the delta and theta band, and an increase in band power was observed in the alpha2, low-beta and high-beta band. This suggests a spectral shift towards the higher frequencies. The sensorimotor cortices were hardly involved in this shift, and even showed a right-sided suppression of band power in the frequency range between 0.5 and 22 Hz.

3.3. Functional connectivity {#sec0012}
----------------------------

To assess differences in average functional connectivity *per ROI* between DBS ON and DBS OFF, permutation tests were performed for all 90 ROIs in the six frequency bands. Significant differences in cAEC were found for the low-beta band (ten ROIs) and also for the alpha2 band (one ROI) and are listed in [Table 2](#tbl0002){ref-type="table"} (as well as visualized in Supplementary Fig. 2). The regions that showed the largest increases in functional connectivity following stimulation were mainly located in bilateral frontobasal brain regions, whereas regions that showed significant decreases followed a more dispersed pattern (frontal, parietal and temporal lobes, bilaterally).Table 2Significant differences in average cAEC values per region of interest.Table 2Frequency bandAnatomical regionL/RcAEC (DBS ON)cAEC (DBS OFF)↑ or ↓*P*-value (FDR-corrected)**Alpha2**Middle temporal gyrusL0.5040.499↑0.0090Gyrus rectusL0.5140.511↑0.0210Olfactory cortexL0.5150.512↑0.0210Superior frontal gyrus, orbital partL0.5130.510↑0.0210Inferior frontal gyrus, triangular partL0.5110.515↓0.0210Superior frontal gyrusL0.5100.514↓0.0090**Low-beta**Superior parietal gyrusL0.5090.513↓0.0090Anterior cingulate gyrusL0.5110.514↓0.0461Gyrus rectusR0.5120.510↑0.0475Superior frontal gyrus, orbital partR0.5110.509↑0.0399Superior temporal poleR0.5100.512↓0.0475ThalamusL0.5180.512↑0.0475[^2][^3]

3.4. Relationship between clinical motor improvement and functional connectivity changes {#sec0013}
----------------------------------------------------------------------------------------

A significant positive correlation was found between total DBS-related motor improvement (MDS-UPDRS-III) and low-beta cAEC change in the sensorimotor cortices (*r-~SM~ (16)* = 0.58, *p* = 0.011), the whole cortex (*r-~WC~ (16)* = 0.50, *p* = 0.035), and all subcortical regions (*r-~SC~ (16)*= 0.62, *p* = 0.006) ([Fig. 4](#fig0004){ref-type="fig"}). When only the MDS-UPDRS-III subscores for bradykinesia and rigidity were considered, the correlations with low-beta band cAEC change were even stronger (respectively: *r-~SM~ (16)*= 0.61, *p* = 0.007; *r-~WC~ (16)*= 0.70, *p* = 0.001; *r-~SC~ (16)*= 0.76, *p* \< 0.001) ([Fig. 4](#fig0004){ref-type="fig"}). In addition, a significant positive correlation was found between bradykinesia/rigidity subscores and alpha2 band cAEC changes (*r-~SM~ (16)* = 0.57, *p* = 0.014; *r-~WC~ (16)*= 0.72, *p* = 0.001; *r~-SC~ (16)* = 0.68, *p* = 0.002) (Supplementary Table 1). cAEC changes did not correlate significantly with tremor improvement ([Fig. 4](#fig0004){ref-type="fig"}; Supplementary Table 1).Fig. 4Correlation of functional connectivity changes with improvement in motor scores.Scatter plots of clinical improvement values and low-beta functional connectivity changes (averaged for respectively the sensorimotor cortices, whole cortex and subcortical regions). Left: Significant correlations between MDS-UPDRS-III improvement (% comparing ON versus OFF-DBS) and cAEC changes (absolute difference ON versus OFF-DBS). Sensorimotor cortices (*r-~SM~ (16)*= 0.58, *p* = 0.011), whole cortex (*r-~WC~ (16)*= 0.50, *p* = 0.035), and all subcortical regions (*r~-SC~ (16)*= 0.62, *p* = 0.006). Middle: Significant correlations between bradykinesia/rigidity improvement and cAEC changes (*r-~SM~ (16)*= 0.61, *p* = 0.007; *r-~WC~(16)*= 0.70, *p* = 0.001; *r~-SC~ (16)*= 0.76, *p* \< 0.001). Right: Tremor improvement (*n* = 13 patients) and cAEC change, no significant correlation. All correlations tested can be found in Supplementary Table 1.cAEC, corrected Amplitude Envelope Correlation; MDS-UPDRS-III, Movement Disorders Society Unified Parkinson\'s Disease Rating Scale motor ratings.Fig 4

4. Discussion {#sec0014}
=============

In this study, we investigated stimulation effects of STN DBS on whole-brain functional connectivity in 18 Parkinson\'s disease patients. We found that increases in alpha2 and low-beta band functional connectivity were correlated with DBS-related improvements in bradykinesia and rigidity, but not with tremor relief. This suggests that the alleged *anti-kinetic* role of beta band oscillations ([@bib0027]; [@bib0029]; [@bib0046]; [@bib0064]) does not apply when large-scale cortico-cortical and cortico-subcortical functional interactions are taken into account. In addition, and in accordance with previous studies ([@bib0002]; [@bib0004]; [@bib0050]), we found a suppression of sensorimotor cortical oscillatory activity (ranging from delta to low-beta band) against a background of widespread stimulation-related increases in oscillatory brain activity involving the higher frequencies.

4.1. Band power {#sec0015}
---------------

Our present observations confirm previous results on band power changes associated with DBS. Firstly, during DBS ON, throughout the cerebral cortex, higher absolute band powers were observed for the higher frequencies (10--30 Hz), whereas lower absolute band powers were found for the lower frequencies (0.5--8 Hz), which could be interpreted as an overall acceleration of oscillatory brain activity. Furthermore, during DBS ON the alpha peak frequency was significantly higher than during DBS OFF. However, since the DBS ON recording was always the first recording of the day, we cannot exclude the possibility that the order of recordings (for example due to increased drowsiness in subsequent recordings) added to the observed spectral shift. Therefore, we additionally studied spectral power in the ON2 recording, which always took place as the last recording. In Supplementary Fig. 3 we illustrate the band power differences between ON2 and DBS OFF (*n* = 17, data for one patient was excluded due to excessive noise of the ON2 recording): Again, stimulation led to an increase in band power for the higher frequencies (8--30 Hz), and a higher frequency of the alpha peak (DBS ON2 8.64, SD 0.69 vs DBS OFF 8.55, SD 0.65; *t(16)*= 2.06, *p* = 0.056). Hence, we conclude that the observed acceleration of oscillatory brain activity is stimulation related, which is in line with the results of an earlier study ([@bib0004])). This effect has previously been attributed to a non-specific increase in intrinsic alertness, independent of motor function ([@bib0023]; [@bib0042]). Alternatively, it may reflect a stimulation-related "release" of the thalamus, which affects cortical brain rhythms ([@bib0021]). However, we cannot exclude the possibility that noise from the stimulator changes the aperiodic "background" 1/f component of the neural power spectrum, thereby causing a peak frequency shift towards the faster frequencies ([@bib0026]). Secondly, we confirmed alpha and beta band suppression in the sensorimotor regions which was previously observed after DBS in Parkinson\'s disease patients ([@bib0002]; [@bib0050]) and following transcranial direct current stimulation over the sensorimotor cortex in healthy controls ([@bib0062]), although this effect was less distinct in our study. Perhaps the fact that our recordings took place in an eyes-closed condition, during which the posterior dominant alpha rhythm is stronger than during an eyes-open condition, may have "blurred" these specific effects.

4.2. Functional connectivity {#sec0016}
----------------------------

The presently observed correlation between increases in functional connectivity and improvements in bradykinesia and rigidity scores is in contradiction with the observations reported by Silberstein and co-workers, who were the first (and up to now the only) to study the effect of DBS on whole-brain functional connectivity ([@bib0064]). They used coherence analysis of (scalp-recorded) EEG data, obtained in DBS-patients with and without stimulation and found reductions in 10--35 Hz coherence between EEG channels that correlated with overall MDS-UPDRS-III improvement. A potential explanation for the discrepancy with our results is the sensitivity of coherence analysis to volume conduction and band power changes (and thereby signal-to-noise ratio (SNR) changes) ([@bib0061]; [@bib0063]). Indeed, the authors observed positive correlations between therapy-induced power and coherence changes. Hence, taking into account the reduction of (mostly alpha and beta band) power around the sensorimotor cortex due to DBS ([@bib0002]; [@bib0050]), the correlations between reduced coherence and improvement of motor function reported by Silberstein et al. may have been influenced by band power changes. In addition, although unlikely to be the sole explanation for the discrepancy between the two studies, MEG and EEG measure different components of the electromagnetic fields generated by neuronal activity, resulting in different sensitivity profiles ([@bib0024]; [@bib0055]). Importantly, although cortico-subcortical functional connections do seem to matter (Supplementary Fig. 4C), the correlations we observed between increases in functional connectivity and clinical improvement cannot fully be explained by the inclusion of subcortical brain regions in our study, since this correlation remained after excluding cortico-subcortical interactions from our analyses (results not shown).

So far, two MEG-studies have assessed the influence of an acute dopaminergic challenge on whole-brain functional connectivity. Stoffers et al. demonstrated, upon levodopa administration, increases in both short-distance functional connectivity (averaging connectivity values for all possible sensor pairs overlying a lobe; 4--30 Hz) and long-range functional connectivity (averaging values for all possible sensor pairs between two lobes; 13--30 Hz), assessed using the synchronization likelihood (SL). In patients with a strong dopamine-related improvement in motor scores, motor improvement was associated with *decreases* in local beta band SL ([@bib0065]). Although we have confirmed the range of effects of DBS on functional connectivity in this study, i.e. both decreases and increases, strongest bradykinesia and rigidity improvement were related to *increases* in functional connectivity in our study. Again, volume conduction might have played a role in this partial discrepancy, since SL is sensitive to volume conduction/field spread and the functional connectivity analysis was performed in sensor space. Volume conduction/field spread leads to multiple recording sites picking up signals from a single source, which may result in erroneous estimates of functional connectivity ([@bib0063]). The fact that only *local* beta band SL showed the discrepancy described supports the notion that volume conduction/field spread might have affected the relationship that was found. In accordance with this line of reasoning, using a functional connectivity measure that is insensitive to the effects of volume conduction/field spread (phase lag index; PLI) others have also found a positive correlation between functional connectivity changes in the left parietal area and improvement in motor function after a dopamine challenge ([@bib0016]).

In contrast with the aforementioned studies, our main results are not based on an acute DBS stimulation challenge, but rather compares DBS ON with DBS OFF. We did however record acute stimulation data in the optimal settings of the patient at the end of each experiment, namely during condition DBS ON2. Although this recording started immediately after switching on the DBS and stimulation effects may not have been maximally present yet, we again found a significant correlation between functional connectivity increases in the subcortical regions and bradykinesia/rigidity improvement (*r~-SC~ (15)* = 0.57, *p* = 0.017), as well as positive trends for the sensorimotor regions (*r-~SM~ (15)*= 0.43, *p* = 0.088) and the cortex as a whole (*r-~WC~ (15)* = 0.36, *p* = 0.152). Therefore, we conclude that the order of stimulation (first DBS ON recording and then the DBS OFF recording, or the other way around) has not influenced the observed direction of correlations found.

In the present study, a differential effect of DBS on alpha2 and low-beta functional connectivity was found. As shown in Supplementary Fig. 4, in Parkinson\'s disease patients who had a modest clinical response to DBS we observed a decrease in whole-brain functional connectivity, whereas in Parkinson\'s disease patients who had a good clinical response we observed an increase, involving cortico-subcortical connections (Supplementary Fig. 4C). We propose the possibility of a technical as well as a physiological explanation for the observed effect.

The technical explanation involves the potential effect of stimulation artefacts in the DBS ON condition, and thereby the addition of 'noise', onto the reconstructed neuronal signals. The effect of the resulting changes in SNR on source level functional connectivity is complex, but stimulation-related noise may have had a lowering effect on functional connectivity (see [@bib0063]) for further reading). Along this line of reasoning, stimulation could have led to a lowering in global functional connectivity for *all* DBS-patients, on top of which small increases in functional connectivity co-occurred with slight clinical improvement (but were covered by noise-related functional connectivity decreases) and large increases in functional connectivity co-occurred with strong clinical improvement (which became apparent as functional connectivity increases). In Supplementary Fig. 5 we show that the addition of spatially correlated white noise onto brain signals of two of our DBS-patients during DBS OFF indeed leads to a global decrease in estimated low-beta cAEC. This illustrates that the extra noise introduced by deep brain stimulation (simulated here as spatially correlated white noise) could have led to a reduction in estimated functional connectivity values. However, the addition of spatially correlated white noise hardly affected theta cAEC values in one patient. Hence, this effect seems frequency-dependent, and is perhaps related to the more prominent presence of amplitude envelope correlations in the alpha and beta band ([@bib0038]).

An alternative, physiological, explanation for the observed differential effect may lie in the complex balance between the different cortico-subcortical functional circuits that converge in the STN. Stimulation in and around the STN can affect cortical brain regions antidromically via axonal stimulation, and can also have downstream effects on the cortico-striato-thalamic loop. We hypothesize that a shift in balance from antidromic axonal towards downstream activation effects might play a role in the link between better clinical effects and increases in functional connectivity. An overview of the hypothesis can be found in [Fig. 5](#fig0005){ref-type="fig"} and reads as follows:Fig. 5Model of antidromic and downstream activation in STN-DBS.Stimulation effects in the antidromic direction take place upon stimulation of axons of the hyperdirect pathway. These stimulation effects may cause a suppression of band power in frontal cortical brain regions, as well as a lowering of functional connectivity between the frontal cortex and the STN (in blue; see also ([@bib0002]; [@bib0050]; [@bib0059])). At the same time, stimulation effects can propagate in the downstream direction and thereby mainly affect the cortico-striato-thalamic loop. Downstream stimulation effects may lead to an increase in cortical functional connectivity via disinhibition of the thalamus (in red; ([@bib0054]; [@bib0056])).Gpi, internal globus pallidus; SNr, substantia nigra pars reticulate; STN, subthalamic nucleus; DBS, deep brain stimulation. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig 5

Antidromic stimulation effects of axons (en route to other structures, or of axons that terminate in the STN) can affect the motor cortex via the hyperdirect pathway, but can also affect a wide variety of other cortical brain regions ([@bib0003]; [@bib0070]). Stimulation effects downstream from the stimulated STN affect the cortico-striato-thalamic loop. The net effect on functional connectivity might not be the same for antidromic axonal and downstream stimulation effects. A dynamic causal modelling study demonstrated that upon DBS, the effective functional connectivity strength of the hyperdirect and indirect (striato-STN and STN-thalamus) pathway decreased, whereas the strength of the direct cortico-striato-pallido-thalamic pathway increased ([@bib0043]), the latter being suggested by an empirical fMRI study ([@bib0054]), as well as by our own additional visualizations in patients with a good clinical response, who had increases in cortico-subcortical functional connectivity (Supplementary Fig. 4C; although we lack the spatial resolution to draw conclusions on the functional connectivity profiles of individual subcortical brain regions). Via downstream activation effective modulation of the STN could reduce the indirect inhibitory drive from the subthalamic nucleus to the thalamus, which would "release" the thalamus to communicate with cortical brain regions ([@bib0021]; [@bib0056]). Furthermore, beneficial effects of stimulation on the resting motor system were better explained by strengthening the coupling along the direct pathway, and not by reducing coupling along the hyperdirect pathway ([@bib0043]; [@bib0056]). This observation was supported by an MEG study by Oswal et al., who found that a stimulation-related decrease in functional connectivity of the hyperdirect pathway was not related to clinical improvement ([@bib0059]).

We expect the individual anatomy of white matter tracts, as well as the exact stimulation site in and around the STN (illustrated in Supplementary Fig. 6 and Supplementary Table 2), to play a crucial role in the balance between antidromic axonal and downstream activation effects. Clearly, our hypothesis will have to be substantiated in future studies that combine local stimulation effects with whole-brain effects, such as LFP recordings combined with MEG recordings. In addition, the MEG data recorded in our study during stimulation of each individual contact point (data not shown), will be analysed in future studies and may shed further light on this matter.

4.3. Methodological issues {#sec0017}
--------------------------

Several methodological issues deserve consideration. (i) In our study, DBS was off for several minutes before we started the 5 min recording. We expect that stronger DBS-related effects could have been observed if the period between turning off the DBS and the start of the MEG-recording had been longer. During epoch selection, we prioritized epochs from later parts of the recordings. However, considering that at least 50% of the total clinical change seems to occur within 5 min after the DBS is turned off ([@bib0047]), and since we did observe significant changes in brain activity in parallel with a clinical correlate, we believe that our experimental setup was effective. (ii) The MDS-UPDRS-III assessments were always performed 6 months after DBS-placement, whereas the MEG recordings took place between six and fifteen months after surgery. The six months' time period made sure that the patients were measured in a clinically stable state. In one patient the stimulation was switched to a more dorsal contact point in the period between clinical assessments and the MEG recordings, due to non-motor side effects (patient 4). In all other patients, clinical assessments and MEG recordings took place during stimulation of the same contact points and with approximately the same stimulation strength (mean difference left-sided contact points 0.12 mA SD 0.25; right-sided contact points 0.05 mA SD 0.21). Although this separation in time may have affected our results, the correlation between clinical improvement and functional connectivity changes would probably have been even stronger if the MEG recordings and clinical assessments had taken place on the same day.

\(iii\) The use of the temporal extension of tSSS ([@bib0066]; [@bib0067]) allowed us to study brain signals during DBS. Despite the ability of tSSS and beamforming to effectively suppress artefacts (([@bib0034]); see also Supplementary Fig. 7 for the effect of tSSS on magnetometers and gradiometers separately), two sharp stimulation-related peaks were seen in the power spectrum ([Fig. 1](#fig0001){ref-type="fig"}), in line with previous research ([@bib0004]). We are aware that monopolar stimulation is associated with stronger artefacts than bipolar stimulation, but we chose to stimulate in the monopolar setting in our study as this represented the clinical setting of our patients. The peaks appeared not to affect the frequency range below 22 Hz, which encouraged us to separately consider the low-beta band and the high-beta band, and to refrain from analysing the gamma band. The observed relationship between alpha2 and low-beta functional connectivity changes and clinical improvement seem to confirm the validity of our recording and analysis approach. Obviously, the high-beta band results should be interpreted with caution and the stimulation-related increase in high-beta band power ([Fig. 3](#fig0003){ref-type="fig"}) may be related to a stimulation artefact; In addition, the lack of a clinical correlate with high-beta band functional connectivity could also mean that stimulation artefacts affected the reconstruction of the brain signals too much in this band or, alternatively, that high-beta band functional connectivity does not reflect DBS-related clinical improvement. (iv) Methodological advances in beamforming ([@bib0032]; [@bib0036]) allow MEG signals to be projected onto an atlas-based source space encompassing both cortical and subcortical brain regions ([@bib0009]; [@bib0035]). In the present study, this approach enabled us to study large scale cortico-subcortical interactions six months after surgery when 'stun effects' of the DBS placement have disappeared, instead of directly after surgery using LFP analysis with externalised DBS leads. Previous LFP studies have analysed fine-grained interactions between the STN and the cortex (e.g. ([@bib0041]; [@bib0040], [@bib0048]; [@bib0059]), whereas our study lacks this spatial resolution. We were therefore not able to draw conclusions regarding individual subcortical regions, yet our coarser approach is complementary to the existing literature. (v) The lack of a correlation between functional connectivity changes and tremor improvement may reflect a difference in pathophysiological mechanisms underlying bradykinesia/rigidity on the one hand and tremor on the other hand. However, we cannot exclude the possibility of a false-negative finding, since the number of patients suffering from tremor was lower than the number of patients suffering from bradykinesia/rigidity (*n* = 13 versus *n* = 18, respectively). In addition, the lack of correlation may be driven by the patients with 100% tremor improvement, who demonstrated an unexpected lowering of functional connectivity upon stimulation (considering the results for patients with less improvement). However, we do not have a plausible explanation for this observation. (vi) Lastly, the correlations between clinical improvement and functional connectivity changes might have been affected by the stimulation strength or the dopaminergic state of the patients. However, we did not correct for this, since these parameters did not correlate with clinical improvement (correlation LEDD and bradykinesia/rigidity improvement *r*(16) = 0.340, *p* = 0.168; correlation stimulation strength and bradykinesia/rigidity improvement *r*(16) = 0.012, *p* = 0.961).

4.4. Conclusion {#sec0018}
---------------

In conclusion, we found a DBS-related suppression of sensorimotor cortical oscillatory activity against a background of widespread stimulation-related increases in oscillatory brain activity involving the higher frequencies. Increases in alpha2 and low-beta functional connectivity were correlated with bradykinesia/rigidity improvement, but not with tremor improvement. Our results provide new insights in the mechanism of action of DBS as they complement the alleged "anti-kinetic" effect of beta band oscillations, and suggest a "pro-kinetic" effect when large-scale cortico-cortical and cortico-subcortical functional interactions are taken into consideration.
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[^1]: mA, milliampere; µs, microseconds; LEDD, Levodopa Equivalent Daily Dose; MDS-UPDRS-III, Movement Disorders Society Unified Parkinson\'s Disease Rating Scale motor ratings; DBS, Deep Brain Stimulation; M/F, male/female; L/R, left/right; D/DM/VM, Dorsal/Dorsomedial/Ventromedial; Med, medication.

[^2]: Comparison between the DBS ON state and the DBS OFF state. Significance threshold *p* \< 0.05.

[^3]: L, Left; R, Right; cAEC, corrected Amplitude Envelope Correlation; DBS, Deep Brain Stimulation; FDR, False Discovery Rate.
